
Sign up to save your podcasts
Or


For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/DCA865. CME/NCPD credit will be available until July 30, 2026.
Off-the-Shelf and on the Mark in NHL: Strategic Approaches With Bispecific Antibodies and ADCs
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from AstraZeneca and Genentech, a member of the Roche Group.
Disclosure information is available at the beginning of the video presentation.
By PVI, PeerView Institute for Medical Education4
1010 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/DCA865. CME/NCPD credit will be available until July 30, 2026.
Off-the-Shelf and on the Mark in NHL: Strategic Approaches With Bispecific Antibodies and ADCs
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from AstraZeneca and Genentech, a member of the Roche Group.
Disclosure information is available at the beginning of the video presentation.

135 Listeners

320 Listeners

496 Listeners

40 Listeners

27 Listeners

10 Listeners

5 Listeners

10 Listeners

4 Listeners

2 Listeners

5 Listeners

2 Listeners

3 Listeners

5 Listeners

5 Listeners

2 Listeners

0 Listeners

9 Listeners

2 Listeners

115 Listeners

2 Listeners

4 Listeners

57 Listeners

3 Listeners

5 Listeners

3,331 Listeners

44 Listeners

22 Listeners

2 Listeners

365 Listeners

54 Listeners

58 Listeners

189 Listeners